Wuhan Tongji Zhongwei Pharmaceutical Co., Ltd.

Primary objective: To compare the pharmacokinetic parameters of the two preparations in healthy subjects, and to evaluate the bioequivalence of the two preparations in both fasting and postprandial states, using rivaroxaban tablets (10 mg) produced by Wuhan Jianmin Zhongwei Pharmaceutical Co., Ltd. as the test preparation and rivaroxaban tablets (10 mg) produced by Bayer AG as the reference preparation. Secondary objective: To observe the safety of the test preparation rivaroxaban tablets and the reference preparation rivaroxaban tablets in healthy subjects.